Related Experiment Video

Updated: Jul 5, 2025

Rat Model of Blood-brain Barrier Disruption to Allow Targeted Neurovascular Therapeutics
08:43

Rat Model of Blood-brain Barrier Disruption to Allow Targeted Neurovascular Therapeutics

Published on: November 30, 2012

20.3K

Targeted nucleic acid delivery for traumatic brain injury: Overcoming blood-brain barrier challenges

Jiayu Zhang1, Jun Chen1

  • 1CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Multi-disciplinary Research Division, Institute of High Energy Physics and University of Chinese Academy of Sciences (UCAS), Chinese Academy of Sciences (CAS), Beijing 100049, P.R. China.

Molecular Therapy. Nucleic Acids
|January 18, 2024
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Heterotopic Mucosal Engrafting Procedure for Direct Drug Delivery to the Brain in Mice
08:25

Heterotopic Mucosal Engrafting Procedure for Direct Drug Delivery to the Brain in Mice

Published on: July 16, 2014

10.8K
Focused Ultrasound Induced Blood-Brain Barrier Opening for Targeting Brain Structures and Evaluating Chemogenetic Neuromodulation
08:37

Focused Ultrasound Induced Blood-Brain Barrier Opening for Targeting Brain Structures and Evaluating Chemogenetic Neuromodulation

Published on: December 22, 2020

3.6K

Related Experiment Videos

Last Updated: Jul 5, 2025

Rat Model of Blood-brain Barrier Disruption to Allow Targeted Neurovascular Therapeutics
08:43

Rat Model of Blood-brain Barrier Disruption to Allow Targeted Neurovascular Therapeutics

Published on: November 30, 2012

20.3K
Heterotopic Mucosal Engrafting Procedure for Direct Drug Delivery to the Brain in Mice
08:25

Heterotopic Mucosal Engrafting Procedure for Direct Drug Delivery to the Brain in Mice

Published on: July 16, 2014

10.8K
Focused Ultrasound Induced Blood-Brain Barrier Opening for Targeting Brain Structures and Evaluating Chemogenetic Neuromodulation
08:37

Focused Ultrasound Induced Blood-Brain Barrier Opening for Targeting Brain Structures and Evaluating Chemogenetic Neuromodulation

Published on: December 22, 2020

3.6K

Related Concept Videos

The Blood-brain Barrier00:49

The Blood-brain Barrier

47.4K
Overview
47.4K

Articles linked to this work by shared authors, journal, and citation graph.

The interaction between dysfunction of vasculature and tauopathy in Alzheimer's disease and related dementias.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

N4-Acetylcytidine-Mediated CD2BP2-DT Drives YBX1 Phase Separation to Stabilize CDK1 and Promote Breast Cancer Progression.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025

Co-occurrence and co-expression of antibiotic, biocide, and metal resistance genes with mobile genetic elements in microbial communities subjected to long-term antibiotic pressure: Novel insights from metagenomics and metatranscriptomics.

Journal of hazardous materials·2025

A refined analysis of Neanderthal-introgressed sequences in modern humans with a complete reference genome.

Genome biology·2025

Reversing Photodynamic Therapy-Induced Tumor Metabolic Symbiosis and Immune Evasion Delivers a Two-Punch Attack on Tumors.

Small (Weinheim an der Bergstrasse, Germany)·2025

Material basis revelation of anti-hepatoma effect of Huachansu (Cinobufacini) through down-regulation of thymidylate synthase.

Chinese herbal medicines·2025

To scramble or not: Steric blocking 2'-MOE/PS control antisense oligonucleotides across cellular models.

Molecular therapy. Nucleic acids·2026

PCBP2 facilitates miR-93-5p-mediated repression of GDF11 in HCC cell lines.

Molecular therapy. Nucleic acids·2026

miRNA-34a-5p is a novel biomarker and modulator of the radioresponse in esophageal adenocarcinoma.

Molecular therapy. Nucleic acids·2026

Retraction Notice to: lncRNA TRMP-S directs dual mechanisms to regulate p27-mediated cellular senescence.

Molecular therapy. Nucleic acids·2026

Next-generation macrophage engineering in cancer therapy: From TAM reprogramming to CAR-macrophages.

Molecular therapy. Nucleic acids·2026

Retraction Notice to: Long Non-coding RNA Profiling Reveals an Abundant MDNCR that Promotes Differentiation of Myoblasts by Sponging miR-133a.

Molecular therapy. Nucleic acids·2026

A Post-NGP Mitsuokella jalaludinii as a Therapeutic Candidate for Gout.

MicrobiologyOpen·2026

Insights into the mechanism of action of the bipartite fusion module of SARS-CoV-2 spike protein.

Journal of virology·2026

Engineered Exosomes for Oral Administration: Breaking Gastrointestinal Barriers for Disease Therapy.

Journal of drug targeting·2026

Molecular basis of tRNA substrate recognition and modification by the atypical SPOUT methyltransferase Trm10.

Nucleic acids research·2026

Natural Missplicing Events Amplified by an Elusive Deep-Intronic MYBPC3 Variant Cause Hypertrophic Cardiomyopathy.

Circulation·2026

Artificial Intelligence in Predicting Systemic Complications From Retinal Findings: A New Frontier in Precision Medicine.

Cureus·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us